Patient-reported Symptoms Differ Between Patients With Brain Metastasis Starting Either Focal Stereotactic Radiotherapy or Whole-brain Radiotherapy
Authors:
- Carsten NiederCNCarsten Nieder
- Annette M. WintherAWAnnette M. Winther
- Silje K. JohnsenSJSilje K. Johnsen
- Ellinor C. HauklandEHEllinor C. Haukland
Open Access
- 1 March 2026
- journal article
- Published by International Institute of Anticancer Research in Cancer Diagnosis & Prognosis
- Vol. 6 (2) , 227-235
Abstract
Background/Aim: The presence of brain metastasis is often associated with clinical symptoms and reduced quality-of life scores, potentially triggering palliative care needs. Previous studies have employed the Edmonton symptom assessment system (ESAS) to this end. However, contemporary patient-reported ESAS data from cohorts managed with different radiotherapy techniques rather than whole-brain radiotherapy (WBRT) alone are scarce. Therefore, the aim of this study was to compare ESAS symptom severity before WBRT to that before stereotactic radiosurgery or fractionated radiotherapy (SRS/FSRT). Materials and Methods: This was a retrospective analysis (2013-2024, n=102) of patients with brain metastasis assessed with ESAS in routine clinical practice in Norway. Patients were stratified based on radiotherapy approach (WBRT±boost versus SRS/FSRT). ESAS scores of 0 correspond to absence of symptoms (maximum intensity: 10). Results: For the whole study group, fatigue and overall wellbeing scores were highest (mean 3.9 and 3.4, respectively). The lowest scores were those for nausea and constipation (mean 1.2 and 1.4, respectively). Within the WBRT cohort, no significant differences were observed between ESAS scores of boost versus no boost patients. When comparing WBRT to SRS/FSRT, we found that WBRT patients reported significantly higher anxiety scores (mean 2.6 vs. 1.1, p=0.03). Similar trends emerged for fatigue (mean 4.1 vs. 2.7, p=0.056, i.e., not significant) and overall wellbeing (mean 3.7 vs. 2.5, p=0.087). The sum of symptom scores was significantly higher in the WBRT cohort (mean 31.7), compared to the SRS/FSRT cohort (mean 18.5), p=0.03. Conclusion: When employing ESAS screening to provide additional palliative care services to patients with brain metastasis who start radiotherapy, clinicians should be aware of the fact that patients undergoing WBRT may have worse symptom burden and higher needs than patients undergoing SRS/FSRT. This is particularly evident for anxiety, fatigue and overall wellbeing, and not explained by differences in number of brain metastasis and diagnostic setting (regular imaging surveillance versus clinical trigger).Keywords
This publication has 29 references indexed in Scilit:
- Quality of life in patients with limited (1–3) brain metastases undergoing stereotactic or whole brain radiotherapyStrahlentherapie und Onkologie, 2019
- Prognostic and predictive factors in patients with brain metastases from solid tumors: A review of published nomogramsCritical Reviews in Oncology/Hematology, 2018
- Patient-reported symptoms before palliative radiotherapy predict survival differencesStrahlentherapie und Onkologie, 2018
- Quality of life after whole brain radiotherapy compared with radiosurgery of the tumor bed: results from a randomized trialClinical and Translational Oncology, 2017
- Fatigue scores in patients with brain metastases receiving whole brain radiotherapySupportive Care in Cancer, 2014
- Predictive Factors for Well-being in Advanced Cancer Patients Referred for Palliative RadiotherapyClinical Oncology, 2012
- Prospective evaluation of quality of life effects in patients undergoing palliative radiotherapy for brain metastasesBMC Cancer, 2012
- What does the answer mean? A qualitative study of how palliative cancer patients interpret and respond to the Edmonton Symptom Assessment SystemPalliative Medicine, 2011
- Prospective Assessment of Patient-Rated Symptoms Following Whole Brain Radiotherapy for Brain MetastasesJournal of Pain and Symptom Management, 2005
- The Edmonton Symptom Assessment System (ESAS): A Simple Method for the Assessment of Palliative Care PatientsJournal of Palliative Care, 1991